23andMe Stock Plunges on Multiple Challenges
Fri, Feb 2, 2024 ET
1min read
ME --
23andMe stock is declining as the company faces multiple challenges such as financial losses, hacks breaching customer data and lawsuits [1],[2],[5]. Its market valuation collapsed from $6 billion to $345 million as the share price kept falling [1]. The company also saw failed expansion plans into new areas like telehealth [2].